Patent Assignment
Reel/Frame 056077/0341
Assignment of Assignor's Interest
Recorded: 2021-04-28
Pages: 9
Assignors
XU, YONG
Executed: 2014-01-28
BRENNING, BEJAMIN GARY
Executed: 2014-04-30
KULTGEN, STEVEN G.
Executed: 2014-01-28
LIU, XIAOHUI
Executed: 2014-02-05
SAUNDERS, MICHAEL DAVID
Executed: 2014-03-12
HO, KOC-KAN
Executed: 2014-04-07
Assignee
TOLERO PHARMACEUTICALS, INC.
3900 N. TRAVERSE MOUNTAIN BLVD., LEHI, UTAH, 84043
Covered Property
(1)
Substituted Imidazo[1,2-B]Pyridazines as Protein Kinase Inhibitors
Application:
17/090,857 →
Publication:
US 2021/0238183
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger
Apr 28, 2021
From: TOLERO PHARMACEUTICALS, INC.
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 056065/0763 →
Change of Name
Apr 28, 2021
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 056077/0354 →
Change of Name
Apr 25, 2022
From: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA ONCOLOGY, INC.
Reel/Frame 059787/0758 →
Merger
Sep 18, 2024
From: SUMITOMO PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA AMERICA, INC.
Reel/Frame 068618/0375 →